Piper Sandler Has Lowered Expectations for Vicarious Surgical (NYSE:RBOT) Stock Price

Vicarious Surgical (NYSE:RBOT) had its price target reduced by Piper Sandler from $12.00 to $10.50 in a research note released on Wednesday morning,Benzinga reports. Piper Sandler currently has a neutral rating on the stock.

Vicarious Surgical Stock Down 11.0 %

Shares of RBOT stock opened at $9.36 on Wednesday. The business has a fifty day simple moving average of $7.11 and a 200 day simple moving average of $7.66. The company has a market cap of $55.20 million, a P/E ratio of -0.91 and a beta of 1.02. Vicarious Surgical has a twelve month low of $4.27 and a twelve month high of $21.43.

Vicarious Surgical Company Profile

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.